Melanotan II (MT2) 10mg

$50.00

Melanotan II is a research peptide supplied strictly for laboratory research use only. This compound is intended for scientific applications and is not for human or animal consumption. Burly Labs prioritizes premium quality, secure packaging, and careful handling for all research products.

Availability: In stock (can be backordered)

Category:

About this product

Length: 7 amino-acid residues

Approximate molecular weight: 1,024.2 g/mol

Structural feature: Constrained cyclic peptide with nonstandard residues.

Molecular structure

Melanotan II is a cyclic peptide analogue of the melanocortin peptide family. Its structure contains a constrained ring and nonstandard amino-acid residues, including D-phenylalanine and norleucine.

Cyclization restricts the conformational freedom of the backbone compared with a corresponding linear peptide. This can affect the orientation of aromatic and charged side chains, which are important for molecular recognition.

Physicochemical properties

The molecule contains both hydrophobic and polar regions. Its ionization state depends on pH, while its conformational behavior depends on solvent and temperature. The precise molecular mass also depends on the defined terminal groups and chemical form.

Biochemical mechanisms

Melanotan II interacts with melanocortin receptors, a family of G-protein-coupled receptors. The receptor subtypes differ in ligand recognition and signaling properties, so activity at one subtype should not be assumed to establish equivalent activity at all others.

Scientific evidence

The cyclic peptide structure is well defined. Receptor selectivity and relative potency are separate properties that require experimental measurement.

Melanotan II is supplied strictly for research use only and is not intended for human or animal consumption, clinical application, diagnostic use, or therapeutic purposes.

Melanotan II peptide research vial Burly LabsMelanotan II (MT2) 10mg
$50.00

Availability: In stock (can be backordered)

Scroll to Top